FDA.reportPublic FDA data

Application 090097

Type
ANDA
Sponsor
MAYNE PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.005MG BASENoNo
002LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.025MG BASENoNo
003LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.05MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0179-0238Liothyronine SodiumLiothyronine SodiumKAISER FOUNDATION HOSPITAANDACurrent
0574-0220Liothyronine SodiumLiothyronine SodiumPaddock Laboratories, LLCANDACurrent
0574-0222Liothyronine SodiumLiothyronine SodiumPaddock Laboratories, LLCANDACurrent
0574-0223Liothyronine SodiumLiothyronine SodiumPaddock Laboratories, LLCANDACurrent
33261-964Liothyronine SodiumLiothyronine SodiumAidarex Pharmaceuticals LLCANDACurrent
43063-252Liothyronine SodiumLiothyronine SodiumPD-Rx Pharmaceuticals, InANDACurrent
43063-253Liothyronine SodiumLiothyronine SodiumPD-Rx Pharmaceuticals, InANDACurrent
51407-384Liothyronine SodiumLiothyronine SodiumGolden State Medical SupplyANDACurrent
51407-384Liothyronine SodiumLiothyronine SodiumGolden State Medical SupplyANDACurrent
51407-385Liothyronine SodiumLiothyronine SodiumGolden State Medical SupplyANDACurrent
51407-385Liothyronine SodiumLiothyronine SodiumGolden State Medical SupplyANDACurrent
51407-386Liothyronine SodiumLiothyronine SodiumGolden State Medical SupplyANDACurrent
51862-320Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
51862-320Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
51862-321Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
51862-321Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
51862-322Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
51862-322Liothyronine SodiumLiothyronine SodiumMayne PharmaANDACurrent
61919-239LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMDIRECT RXANDACurrent
61919-239LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMDIRECT RXANDACurrent
63629-7002Liothyronine SodiumLiothyronine SodiumBryant Ranch PrepackANDACurrent
68071-2133Liothyronine SodiumLiothyronine SodiumNuCare Pharmaceuticals, Inc.ANDACurrent
68151-0237Liothyronine SodiumLiothyronine SodiumCarilion Materials ManagementANDACurrent
68151-0238Liothyronine SodiumLiothyronine SodiumCarilion Materials ManagementANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
22706ORIG2011-12-09